BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32320046)

  • 1. Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases.
    Wang Y; Long W; Cao Y; Li J; You L; Fan Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32320046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stromal/Stem Cell Extracellular Vesicles and Perinatal Injury: One Formula for Many Diseases.
    Delavogia E; Ntentakis DP; Cortinas JA; Fernandez-Gonzalez A; Alex Mitsialis S; Kourembanas S
    Stem Cells; 2022 Nov; 40(11):991-1007. PubMed ID: 36044737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Applications of Extracellular Vesicles: Perspectives from Newborn Medicine.
    Willis GR; Kourembanas S; Mitsialis SA
    Methods Mol Biol; 2017; 1660():409-432. PubMed ID: 28828676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells in neonatal diseases: An overview.
    Chaubey S; Bhandari V
    Semin Fetal Neonatal Med; 2022 Feb; 27(1):101325. PubMed ID: 35367186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
    Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the therapeutic potential of the stem cell secretome in neonatal diseases.
    Tung S; Delavogia E; Fernandez-Gonzalez A; Mitsialis SA; Kourembanas S
    Semin Perinatol; 2023 Apr; 47(3):151730. PubMed ID: 36990921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation.
    Lesage F; Thébaud B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis.
    Takeuchi R; Katagiri W; Endo S; Kobayashi T
    PLoS One; 2019; 14(11):e0225472. PubMed ID: 31751396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Good things come in small packages": application of exosome-based therapeutics in neonatal lung injury.
    Willis GR; Mitsialis SA; Kourembanas S
    Pediatr Res; 2018 Jan; 83(1-2):298-307. PubMed ID: 28985201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The morbidities of extremely preterm and extremely low birth weight infants during hospitalization].
    ;
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):334-40. PubMed ID: 26080662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
    Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
    Front Immunol; 2018; 9():2837. PubMed ID: 30564236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs.
    Qiu G; Zheng G; Ge M; Wang J; Huang R; Shu Q; Xu J
    Stem Cell Res Ther; 2018 Nov; 9(1):320. PubMed ID: 30463593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
    Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
    J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
    Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Cells; 2019 May; 8(5):. PubMed ID: 31100966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth.
    Laube M; Stolzing A; Thome UH; Fabian C
    Int J Biochem Cell Biol; 2016 May; 74():18-32. PubMed ID: 26928452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
    Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
    Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.